California-based Geron was once feared for its patent might. Because the company held exclusive rights to many embryonic stem cells developed at the University of Wisconsin, biotechnology rivals believed the company would establish a stem cell monopoly. In 1999 Geron purchased rights to the cloning technology used to make Dolly the sheep in Scotland, a technique given patent protection by the British government a year later.
Office of Strategic Communication